ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $291,344 | -33.2% | 48,156 | -14.3% | 0.00% | – |
| Q2 2023 | $435,879 | -18.9% | 56,170 | -40.4% | 0.00% | – |
| Q1 2023 | $537,618 | +510.9% | 94,319 | +242.3% | 0.00% | – |
| Q3 2022 | $88,000 | -68.6% | 27,557 | -55.8% | 0.00% | – |
| Q2 2022 | $280,000 | -13.0% | 62,387 | +3.5% | 0.00% | – |
| Q1 2022 | $322,000 | -50.1% | 60,306 | +37.3% | 0.00% | – |
| Q4 2021 | $645,000 | -23.7% | 43,915 | +8.6% | 0.00% | – |
| Q3 2021 | $845,000 | +41.8% | 40,421 | +19.9% | 0.00% | – |
| Q2 2021 | $596,000 | -7.6% | 33,703 | +28.1% | 0.00% | – |
| Q1 2021 | $645,000 | +7.0% | 26,320 | +47.7% | 0.00% | – |
| Q4 2020 | $603,000 | +77.9% | 17,822 | +31.6% | 0.00% | – |
| Q3 2020 | $339,000 | -2.0% | 13,544 | +32.0% | 0.00% | – |
| Q2 2020 | $346,000 | – | 10,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $116,820,000 | 11.19% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $14,756,000 | 9.10% |
| Euclidean Capital LLC | 996,734 | $24,420,000 | 8.17% |
| Invus Financial Advisors, LLC | 1,007,575 | $24,686,000 | 5.66% |
| EcoR1 Capital, LLC | 3,092,218 | $75,759,000 | 3.36% |
| Ally Bridge Group (NY) LLC | 413,061 | $10,120,000 | 1.94% |
| EMERALD ADVISERS, LLC | 615,511 | $15,080,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $57,271,000 | 0.54% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 624,210 | $15,293,000 | 0.51% |
| Casdin Capital, LLC | 601,515 | $14,737,000 | 0.44% |